1. Home
  2. WTFCN vs BCTXL Comparison

WTFCN vs BCTXL Comparison

Compare WTFCN & BCTXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred StocK

WTFCN

Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred StocK

HOLD

Current Price

$26.40

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo BriaCell Therapeutics Corp. Warrant expiring 2031

BCTXL

BriaCell Therapeutics Corp. Warrant expiring 2031

N/A

Current Price

$0.98

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WTFCN
BCTXL
Founded
N/A
N/A
Country
United States
Canada
Employees
5902
4
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WTFCN
BCTXL
Price
$26.40
$0.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.5K
29.6K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.55
$0.77
52 Week High
$27.31
$1.40

Technical Indicators

Market Signals
Indicator
WTFCN
BCTXL
Relative Strength Index (RSI) 59.22 44.80
Support Level $26.15 $0.92
Resistance Level $26.36 $1.25
Average True Range (ATR) 0.15 0.10
MACD 0.06 -0.01
Stochastic Oscillator 89.38 46.49

Price Performance

Historical Comparison
WTFCN
BCTXL

About WTFCN Wintrust Financial Corporation Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Preferred StocK

Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. Its operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.

About BCTXL BriaCell Therapeutics Corp. Warrant expiring 2031

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: